# Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT

> **NCT04423237** · — · COMPLETED · sponsor: **University of Pisa** · enrollment: 39 (actual)

## Conditions studied

- Iron Overload

## Interventions

- **DRUG:** Deferasirox

## Key facts

- **NCT ID:** NCT04423237
- **Lead sponsor:** University of Pisa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-30
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2025-06-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04423237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04423237, "Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04423237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*